1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
Paulsson, J. ; Rydén, Lisa LU
; Strell, C
; Frings, O
; Tobin, Nicholas P
LU
; Fornander, T.
; Bergh, J.
; Landberg, Göran
LU
; Ståhl, O.
and Östman, A.
(2017)
In The Journal of Pathology: Clinical Research
3(1).
p.38-43
- Contribution to journal › Article
- 2014
-
Mark
Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.
Lehn, Sophie LU ; Tobin, Nicholas P LU ; Sims, Andrew H ; Stål, Olle ; Jirström, Karin LU
; Axelson, Håkan
LU
and Landberg, Göran
LU
(2014)
In BMC Cancer
14(1).
- Contribution to journal › Article
- 2011
-
Mark
Stromal Expression of β-Arrestin-1 Predicts Clinical Outcome and Tamoxifen Response in Breast Cancer.
Lundgren, Katja LU ; Tobin, Nicholas P LU ; Lehn, Sophie LU ; Stål, Olle ; Rydén, Lisa LU
; Jirström, Karin
LU
and Landberg, Göran
LU
(2011)
In The Journal Of Molecular Diagnostics
13(3).
p.340-351
- Contribution to journal › Article
- 2010
-
Mark
Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features.
Lehn, Sophie LU ; Tobin, Nicholas P LU ; Berglund, Pontus LU ; Nilsson, Kristina LU ; Sims, Andrew H ; Jirström, Karin LU
; Härkönen, Pirkko
LU
; Lamb, Rebecca
and Landberg, Göran
LU
(2010)
In American Journal of Pathology
177.
p.2886-2897
- Contribution to journal › Article